Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen
Kidney International · 2025
DOI: 10.1016/j.kint.2025.01.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Peter J Eggenhuizen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Anti-Glomerular Basement Membrane Disease, Collagen Type IV, Autoimmunity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC, Lupus Research Alliance, Ramaciotti Foundations.
Abstract (Originalsprache)
Anti–glomerular basement membrane (anti-GBM) disease is accompanied by insufficient antigen-specific regulatory T cells (Tregs) and clonally expanded antigen-specific conventional T cells. In particular, this applied to the immunodominant T cell autoepitope of type IV collagen, α3(IV)NC1 135–145 , presented by human leukocyte antigen–DRB1∗1501. Here, we investigated whether Tregs engineered to express GBM–T cell receptors (TCR) specific for α3(IV)NC1 135–145 better suppress autoimmunity. The GBM-TCR Treg cell product exhibited a phenotypically stable Treg phenotype, produced α3(IV)NC1 135–145 –specific functional responses, and were superior suppressors of autoreactive conventional T cells and bystander conventional T cells compared to polyclonal Tregs or irrelevant TCR-transduced Tregs. We also found that GBM-TCR Tregs modulate other immune cells like dendritic cells and B cells to a more tolerogenic phenotype. Importantly, our findings support the development of GBM-TCR Tregs as a promising cell-based therapy for anti-GBM disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia; Department of Hematology, the Affiliated Zhuzhou Hospital of Xiangya Medical Colleg…
- Alfred Research Alliance Flow Cytometry Core Facility, Melbourne, Victoria, Australia.
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Chi…
- Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia. Electronic address: joshua.ooi@monash.edu.
Förderung
- NHMRC
- Lupus Research Alliance
- Ramaciotti Foundations
- Rebecca L Cooper Medical Research Foundation
Zitieren
APA
Eggenhuizen, P. J., Ng, B. H., Lo, C., Chang, J., Snelgrove, S. L., Cheong, R. M. Y., Shen, C., Lim, S., Zhong, Y., Gan, P. Y., & Ooi, J. D. (2025). Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen. Kidney International. https://doi.org/10.1016/j.kint.2025.01.005
Vancouver
Eggenhuizen PJ, Ng BH, Lo C, Chang J, Snelgrove SL, Cheong RMY, et al. Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen. Kidney International. 2025. doi:10.1016/j.kint.2025.01.005
BibTeX
@article{Eggenhuizen2025,
author = {Eggenhuizen, Peter J and Ng, Boaz H and Lo, Cecilia and Chang, Janet and Snelgrove, Sarah L and Cheong, Rachel M Y and Shen, Chanjuan and Lim, Steven and Zhong, Yong and Gan, Poh-Yi and Ooi, Joshua D},
title = {Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen},
journal = {Kidney International},
year = {2025},
doi = {10.1016/j.kint.2025.01.005}
}
EUVIMED